Literature DB >> 10735838

A comparison of local anaesthetics for venepuncture.

J Arrowsmith1, C Campbell.   

Abstract

AIM: To compare the effectiveness of EMLA cream and Ametop gel in providing analgesia for venous cannulation.
METHODS: Single blind study in 120 children.
RESULTS: Both anaesthetic agents produced adequate analgesia. However, Ametop gel was more effective, with a statistically significant difference in the pain scores of the two groups (p < 0.05).

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10735838      PMCID： PMC1718269          DOI： 10.1136/adc.82.4.309

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Male adolescents and physician sex preference.

Authors:  C J Van Ness; D A Lynch
Journal:  Arch Pediatr Adolesc Med       Date:  2000-01

2.  Clinical experiences with a novel percutaneous amethocaine preparation: prevention of pain due to venepuncture in children.

Authors:  A D Woolfson; D F McCafferty; V Boston
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

3.  Evaluation of an amethocaine gel preparation for percutaneous analgesia before venous cannulation in children.

Authors:  R A Lawson; N G Smart; A C Gudgeon; N S Morton
Journal:  Br J Anaesth       Date:  1995-09       Impact factor: 9.166

Review 4.  Age-related response to lidocaine-prilocaine (EMLA) emulsion and effect of music distraction on the pain of intravenous cannulation.

Authors:  S E Arts; H H Abu-Saad; G D Champion; M R Crawford; R J Fisher; K H Juniper; J B Ziegler
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

5.  Comparison of percutaneous anaesthesia for venous cannulation after topical application of either amethocaine or EMLA cream.

Authors:  J Molodecka; C Stenhouse; J M Jones; A Tomlinson
Journal:  Br J Anaesth       Date:  1994-02       Impact factor: 9.166
  5 in total
  8 in total

1.  Does EMLA cream application interfere with the success of venipuncture or venous cannulation? A prospective multicenter observational study.

Authors:  S Schreiber; L Ronfani; G P Chiaffoni; L Matarazzo; M Minute; E Panontin; F Poropat; C Germani; E Barbi
Journal:  Eur J Pediatr       Date:  2012-10-24       Impact factor: 3.183

Review 2.  WITHDRAWN: EMLA and Amethocaine for reduction of children's pain associated with needle insertion.

Authors:  Janice A Lander; Belinda J Weltman; Sharon S So
Journal:  Cochrane Database Syst Rev       Date:  2014-03-13

Review 3.  A critical review of the topical local anesthetic amethocaine (Ametop) for pediatric pain.

Authors:  Lisa O'Brien; Anna Taddio; Dorothy A Lyszkiewicz; Gideon Koren
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

4.  Pain assessment and management: The knowledge, attitude and practice of Sudanese Paediatric Residents.

Authors:  Mohammed A A Alhassan; Fathelrahman E Ahmed; Abdolmoneim A Bannaga
Journal:  Sudan J Paediatr       Date:  2017

5.  Pain during venous cannulation: Double-blind, randomized clinical trial of analgesic effect between topical amethocaine and eutectic mixture of local anesthetic.

Authors:  Cn Yeoh; Cy Lee
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-04

Review 6.  Sedation analgesia in pediatric intensive care.

Authors:  M N G Nair; S K Jatana
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 5.319

7.  How effective is tetracaine 4% gel, before a peripherally inserted central catheter, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial [ISRCTN75884221].

Authors:  Brigitte Lemyre; Rebecca Sherlock; Debora Hogan; Isabelle Gaboury; Colline Blanchard; David Moher
Journal:  BMC Med       Date:  2006-05-03       Impact factor: 8.775

8.  How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial.

Authors:  Brigitte Lemyre; Debora L Hogan; Isabelle Gaboury; Rebecca Sherlock; Colline Blanchard; David Moher
Journal:  BMC Pediatr       Date:  2007-02-08       Impact factor: 2.125
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.